BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sacchi MC, Tamiazzo S, Stobbione P, Agatea L, De Gaspari P, Stecca A, Lauritano EC, Roveta A, Tozzoli R, Guaschino R, Bonometti R. SARS-CoV-2 infection as a trigger of autoimmune response. Clin Transl Sci 2021;14:898-907. [PMID: 33306235 DOI: 10.1111/cts.12953] [Cited by in Crossref: 10] [Cited by in F6Publishing: 30] [Article Influence: 10.0] [Reference Citation Analysis]
Number Citing Articles
1 Zheng Q, Wang D, Lin R, Lv Q, Wang W. IFI44 is an immune evasion biomarker for SARS-CoV-2 and Staphylococcus aureus infection in patients with RA. Front Immunol 2022;13:1013322. [DOI: 10.3389/fimmu.2022.1013322] [Reference Citation Analysis]
2 Chen S, Guan F, Candotti F, Benlagha K, Camara NOS, Herrada AA, James LK, Lei J, Miller H, Kubo M, Ning Q, Liu C. The role of B cells in COVID-19 infection and vaccination. Front Immunol 2022;13:988536. [DOI: 10.3389/fimmu.2022.988536] [Reference Citation Analysis]
3 Blum FR, Sampath AJ, Gilbert AL, Foulke GT. Diffuse systemic sclerosis following COVID-19 infection. Scand J Rheumatol 2022;:1-3. [PMID: 35946910 DOI: 10.1080/03009742.2022.2103935] [Reference Citation Analysis]
4 Lee LE, Jeong W, Park YB, Jeong SJ, Lee SW. Clinical Significance of Antineutrophil Cytoplasmic Antibody Positivity in Patients Infected with SARS-CoV-2. J Clin Med 2022;11:4152. [PMID: 35887916 DOI: 10.3390/jcm11144152] [Reference Citation Analysis]
5 de Belo IA, Gouveia C, Milheiro Silva T, Conde M. COVID-19 infection triggered juvenile systemic lupus erythematosus-like disease. J Paediatr Child Health 2022. [PMID: 35838138 DOI: 10.1111/jpc.16116] [Reference Citation Analysis]
6 Mcgill JR, Lagassé HAD, Hernandez N, Hopkins L, Jankowski W, Mccormick Q, Simhadri V, Golding B, Sauna ZE. A structural homology approach to identify potential cross-reactive antibody responses following SARS-CoV-2 infection. Sci Rep 2022;12. [DOI: 10.1038/s41598-022-15225-3] [Reference Citation Analysis]
7 Melayah S, Mankaï A, Jemni M, Ben Chaben A, Ghozzi M, Ben Abdelkrim A, Ach K, Ghariani N, Denguezli M, Benzarti W, Benzarti M, Melayah S, Naija W, Ghedira I. Anti-Saccharomyces cerevisiae antibodies in patients with COVID-19. Arab Journal of Gastroenterology 2022. [DOI: 10.1016/j.ajg.2022.07.001] [Reference Citation Analysis]
8 Choung HYG, Jean-Gilles J, Goldman B. Subepithelial deposits with microspherular structures in membranous glomerulonephritis. Ultrastruct Pathol 2022;:1-11. [PMID: 35709324 DOI: 10.1080/01913123.2022.2090646] [Reference Citation Analysis]
9 Ameratunga R. SARS-CoV-2 the ASIA virus (autoimmune/autoinflammatory syndrome induced by adjuvants), the risk of infertility and vaccine hesitancy. Expert Rev Vaccines 2022. [PMID: 35695410 DOI: 10.1080/14760584.2022.2089120] [Reference Citation Analysis]
10 Walitt B, Johnson TP. The pathogenesis of neurologic symptoms of the postacute sequelae of severe acute respiratory syndrome coronavirus 2 infection. Curr Opin Neurol 2022;35:384-91. [PMID: 35674083 DOI: 10.1097/WCO.0000000000001051] [Reference Citation Analysis]
11 Ameratunga R, Woon ST, Steele R, Lehnert K, Leung E, Brooks AES. Severe COVID-19 is a T cell immune dysregulatory disorder triggered by SARS-CoV-2. Expert Rev Clin Immunol 2022. [PMID: 35510369 DOI: 10.1080/1744666X.2022.2074403] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
12 Taeschler P, Cervia C, Zurbuchen Y, Hasler S, Pou C, Tan Z, Adamo S, Raeber ME, Bächli E, Rudiger A, Stüssi-Helbling M, Huber LC, Brodin P, Nilsson J, Probst-Müller E, Boyman O. Autoantibodies in COVID-19 correlate with antiviral humoral responses and distinct immune signatures. Allergy 2022. [PMID: 35364615 DOI: 10.1111/all.15302] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
13 Güven SC, Apaydın H, Özdemir B, Armağan B, Ateş İ, Erden A, Küçükşahin O, Omma A. Antineutrophil cytoplasmic antibody positivity and clinical implications in COVID-19. Future Virology. [DOI: 10.2217/fvl-2021-0125] [Reference Citation Analysis]
14 Cheng ZJ, Li B, Zhan Z, Zhao Z, Xue M, Zheng P, Lyu J, Hu C, He J, Chen R, Sun B. Clinical Application of Antibody Immunity Against SARS-CoV-2: Comprehensive Review on Immunoassay and Immunotherapy. Clin Rev Allergy Immunol 2022. [PMID: 35031959 DOI: 10.1007/s12016-021-08912-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Karrow NA, Shandilya UK, Pelech S, Wagter-Lesperance L, McLeod D, Bridle B, Mallard BA. Maternal COVID-19 Vaccination and Its Potential Impact on Fetal and Neonatal Development. Vaccines (Basel) 2021;9:1351. [PMID: 34835282 DOI: 10.3390/vaccines9111351] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
16 Peluso MJ, Donatelli J, Henrich TJ. Long-term immunologic effects of SARS-CoV-2 infection: leveraging translational research methodology to address emerging questions. Transl Res 2021:S1931-5244(21)00269-3. [PMID: 34780969 DOI: 10.1016/j.trsl.2021.11.006] [Reference Citation Analysis]
17 Al-Kindi S, Zidar DA. COVID-lateral damage: cardiovascular manifestations of SARS-CoV-2 infection. Transl Res 2021:S1931-5244(21)00268-1. [PMID: 34780967 DOI: 10.1016/j.trsl.2021.11.005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
18 Otaki JM, Nakasone W, Nakamura M. Self and Nonself Short Constituent Sequences of Amino Acids in the SARS-CoV-2 Proteome for Vaccine Development. COVID 2021;1:555-74. [DOI: 10.3390/covid1030047] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
19 Peluso MJ, Thomas IJ, Munter SE, Deeks SG, Henrich TJ. Lack of Antinuclear Antibodies in Convalescent COVID-19 Patients with Persistent Symptoms. Clin Infect Dis 2021:ciab890. [PMID: 34617982 DOI: 10.1093/cid/ciab890] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
20 Seeßle J, Naujokat C, Oberacker P, Peters WH, Waterboer T, Müller B, Merle U. Reply to Peluso, et al. Clin Infect Dis 2021:ciab892. [PMID: 34617996 DOI: 10.1093/cid/ciab892] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
21 Tariq J, Chatterjee T, Andreoli L, Gupta L. COVID-19 and fertility-at the crossroads of autoimmunity and thrombosis. Rheumatol Int 2021;41:1885-94. [PMID: 34455463 DOI: 10.1007/s00296-021-04977-2] [Reference Citation Analysis]
22 Focosi D, Franchini M, Pirofski LA, Burnouf T, Fairweather D, Joyner MJ, Casadevall A. COVID-19 Convalescent Plasma Is More than Neutralizing Antibodies: A Narrative Review of Potential Beneficial and Detrimental Co-Factors. Viruses 2021;13:1594. [PMID: 34452459 DOI: 10.3390/v13081594] [Cited by in Crossref: 1] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
23 Wang JY, Zhang W, Roehrl MW, Roehrl VB, Roehrl MH. An Autoantigen Profile from Jurkat T-Lymphoblasts Provides a Molecular Guide for Investigating Autoimmune Sequelae of COVID-19. bioRxiv 2021:2021. [PMID: 34729561 DOI: 10.1101/2021.07.05.451199] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Seeßle J, Waterboer T, Hippchen T, Simon J, Kirchner M, Lim A, Müller B, Merle U. Persistent symptoms in adult patients one year after COVID-19: a prospective cohort study. Clin Infect Dis 2021:ciab611. [PMID: 34223884 DOI: 10.1093/cid/ciab611] [Cited by in F6Publishing: 55] [Reference Citation Analysis]
25 Fineschi S. Case Report: Systemic Sclerosis After Covid-19 Infection. Front Immunol 2021;12:686699. [PMID: 34262566 DOI: 10.3389/fimmu.2021.686699] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
26 Masuko K. Will the COVID-19 pandemic trigger future occurrence of autoimmunity like Sjögren's syndrome? Int J Rheum Dis 2021;24:963-5. [PMID: 34156141 DOI: 10.1111/1756-185X.14154] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
27 Miedema J, Schreurs M, van der Sar-van der Brugge S, Paats M, Baart S, Bakker M, Hoek R, Dik WA, Endeman H, Van Der Velden V, van Gammeren A, Ermens A, Aerts JG, Thüsen JV. Antibodies Against Angiotensin II Receptor Type 1 and Endothelin A Receptor Are Associated With an Unfavorable COVID19 Disease Course. Front Immunol 2021;12:684142. [PMID: 34054876 DOI: 10.3389/fimmu.2021.684142] [Cited by in Crossref: 1] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
28 Chang SH, Minn D, Kim YK. Autoantibodies in moderate and critical cases of COVID-19. Clin Transl Sci 2021. [PMID: 33934534 DOI: 10.1111/cts.13036] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
29 Wang JY, Zhang W, Roehrl VB, Roehrl MW, Roehrl MH. An Autoantigen-ome from HS-Sultan B-Lymphoblasts Offers a Molecular Map for Investigating Autoimmune Sequelae of COVID-19. bioRxiv 2021:2021. [PMID: 33851168 DOI: 10.1101/2021.04.05.438500] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
30 Anaya JM, Monsalve DM, Rojas M, Rodríguez Y, Montoya-García N, Mancera-Navarro LM, Villadiego-Santana AM, Rodríguez-Leguizamón G, Acosta-Ampudia Y, Ramírez-Santana C. Latent rheumatic, thyroid and phospholipid autoimmunity in hospitalized patients with COVID-19. J Transl Autoimmun 2021;4:100091. [PMID: 33681751 DOI: 10.1016/j.jtauto.2021.100091] [Cited by in Crossref: 6] [Cited by in F6Publishing: 16] [Article Influence: 6.0] [Reference Citation Analysis]